Clinical trial / 2015
Targeted delivery of propionate to the colon stimulated gut hormones, reduced energy intake, and prevented weight gain in overweight adults.
Researchers tested the effects of an inulin-propionate ester using in vitro human colonic cells, an acute randomized controlled crossover trial, and a 24-week randomized controlled study in 60 overweight adults. Acute ingestion of 10 g inulin-propionate ester significantly increased postprandial plasma PYY and GLP-1 and reduced energy intake. Over 24 weeks, supplementation with 10 g/day significantly reduced weight gain, intra-abdominal adipose tissue distribution, and intrahepatocellular lipid content, while preventing the deterioration in insulin sensitivity observed with the inulin control.
- Study type
- In vitro study, acute randomized crossover trial, and 24-week RCT
- Who was studied
- 60 overweight adults in the 24-week study, plus acute trial participants and human colonic cells
- What was measured
- PYY and GLP-1 secretion, energy intake, weight gain, intra-abdominal adipose tissue, intrahepatocellular lipid, and insulin sensitivity
THE PAPER
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults.
Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G. Gut, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.